Does Tadalafil Interact with Sapropterin Dihydrochloride?
CDI records a moderate classification for Tadalafil and Sapropterin Dihydrochloride. The stored summary is: Both sapropterin and PDE-5 inhibitors may induce vasorelaxation, potentially reducing blood pressure. The mechanism involves additive vasorelaxation effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Tadalafil Class
- Phosphodiesterase 5 Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive vasorelaxation effects
What To Tell Your Doctor or Pharmacist
If you are taking Tadalafil and your doctor is considering prescribing Sapropterin Dihydrochloride (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider